GSK Consumer In 2019: Start On Runway Toward Demerger For Deleveraging Debt
Executive Summary
Glaxo's priority for its consumer business is regulatory approval, expected in the second half of 2019, of a JV with Pfizer announced in December so the segment will begin contributing meaningfully to GSK's growth. CEO Emma Walmsley says the JV plan with Pfizer is GSK's "most transformational announcement to date."